Richard S Lindahl - Net Worth and Insider Trading
Richard S Lindahl Net Worth
The estimated net worth of Richard S Lindahl is at least $531,591 dollars as of 2024-12-01. Richard S Lindahl is the EVP, CFO of Emergent BioSolutions Inc and owns about 39,919 shares of Emergent BioSolutions Inc (EBS) stock worth over $403,980. Richard S Lindahl is also the Treasurer of Sprint Corp and owns about 14,804 shares of Sprint Corp (S) stock worth over $127,610. Details can be seen in Richard S Lindahl's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard S Lindahl has not made any transactions after 2021-11-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard S Lindahl
Richard S Lindahl Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard S Lindahl owns 3 companies in total, including Emergent BioSolutions Inc (EBS) , CEB Inc (CEB) , and Compass Therapeutics Inc (CMPX) .
Click here to see the complete history of Richard S Lindahl’s form 4 insider trades.
Insider Ownership Summary of Richard S Lindahl
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EBS | Emergent BioSolutions Inc | 2021-11-15 | EVP & Chief Financial Officer |
CEB | CEB Inc | 2017-04-05 | Chief Financial Officer |
CMPX | Compass Therapeutics Inc | 2023-04-21 | director |
Richard S Lindahl Latest Holdings Summary
Richard S Lindahl currently owns a total of 2 stocks. Among these stocks, Richard S Lindahl owns 39,919 shares of Emergent BioSolutions Inc (EBS) as of November 15, 2021, with a value of $403,980 and a weighting of 75.99%. Richard S Lindahl also owns 14,804 shares of Sprint Corp (S) as of August 19, 2005, with a value of $127,610 and a weighting of 24.01%.
Latest Holdings of Richard S Lindahl
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
EBS | Emergent BioSolutions Inc | 2021-11-15 | 39,919 | 10.12 | 403,980 |
S | Sprint Corp | 2005-08-19 | 14,804 | 8.62 | 127,610 |
Holding Weightings of Richard S Lindahl
Richard S Lindahl Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard S Lindahl has made a total of 1 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Emergent BioSolutions Inc is the acquisition of 3,000 shares on November 15, 2021, which cost Richard S Lindahl around $112,380.
According to the SEC Form 4 filings, Richard S Lindahl has made a total of 0 transactions in Sprint Corp (S) over the past 5 years. The most-recent trade in Sprint Corp is the sale of 49,374 shares on August 19, 2005, which brought Richard S Lindahl around $1 Million.
Insider Trading History of Richard S Lindahl
- 1
Richard S Lindahl Trading Performance
GuruFocus tracks the stock performance after each of Richard S Lindahl's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard S Lindahl is 18.25%. GuruFocus also compares Richard S Lindahl's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard S Lindahl within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard S Lindahl's insider trading performs compared to the benchmark.
Performance of Richard S Lindahl
Richard S Lindahl Ownership Network
Richard S Lindahl Owned Company Details
What does Emergent BioSolutions Inc do?
Who are the key executives at Emergent BioSolutions Inc?
Richard S Lindahl is the EVP & Chief Financial Officer of Emergent BioSolutions Inc. Other key executives at Emergent BioSolutions Inc include SVP & Bioservices William Hartzel , Interim CEO Miller H Haywood Iii , and SVP & Products Business Paul Anthony Williams .
Emergent BioSolutions Inc (EBS) Insider Trades Summary
Over the past 18 months, Richard S Lindahl made no insider transaction in Emergent BioSolutions Inc (EBS). Other recent insider transactions involving Emergent BioSolutions Inc (EBS) include a net sale of 16,449 shares made by Kathryn C Zoon , a net sale of 25,000 shares made by Donald W Degolyer , and a net sale of 14,287 shares made by Marvin L White .
In summary, during the past 3 months, insiders sold 39,287 shares of Emergent BioSolutions Inc (EBS) in total and bought 0 shares, with a net sale of 39,287 shares. During the past 18 months, 55,736 shares of Emergent BioSolutions Inc (EBS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 55,736 shares.
Emergent BioSolutions Inc (EBS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Emergent BioSolutions Inc Insider Transactions
Richard S Lindahl Mailing Address
Above is the net worth, insider trading, and ownership report for Richard S Lindahl. You might contact Richard S Lindahl via mailing address: Nextel, 2001 Edmund Halley Dr, Reston Va 20191.